Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Matinas BioPharma Hldgs Q3 EPS $(0.40) Up From $(0.85) YoY

Author: Benzinga Newsdesk | November 10, 2025 05:49pm
Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.40) per share. This is a 52.94 percent increase over losses of $(0.85) per share from the same period last year.

Posted In: MTNB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist